Compare CRIS & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRIS | CENN |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0M | 12.8M |
| IPO Year | 2000 | 2017 |
| Metric | CRIS | CENN |
|---|---|---|
| Price | $0.71 | $0.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | 136.7K | ★ 795.4K |
| Earning Date | 03-19-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | 18.54 |
| EPS | N/A | ★ N/A |
| Revenue | $9,898,000.00 | ★ $31,297,393.00 |
| Revenue This Year | $32.24 | N/A |
| Revenue Next Year | $66.94 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 31.50 | ★ 41.75 |
| 52 Week Low | $0.67 | $0.10 |
| 52 Week High | $3.13 | $1.10 |
| Indicator | CRIS | CENN |
|---|---|---|
| Relative Strength Index (RSI) | 26.43 | 44.07 |
| Support Level | N/A | $0.10 |
| Resistance Level | $1.04 | $0.17 |
| Average True Range (ATR) | 0.07 | 0.01 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 9.42 | 37.14 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.